SHANGHAI, March 28, 2025 /PRNewswire/ -- Zhejiang Langhua Pharmaceutical Co., Ltd. ("Langhua Pharmaceutical"), a wholly-owned subsidiary of Viva Biotech Holdings ("Viva Biotech"), underwent a cGMP (Current Good Manufacturing Practices) on-site inspection by the U.S. Food and Drug...
Read More Details
Finally We wish PressBee provided you with enough information of ( Viva Biotech's Wholly-Owned Subsidiary Langhua Pharmaceutical Successfully Passes U.S. FDA On-Site Inspection )
Also on site :
- Today’s NYT ‘Strands’ Hints, Spangram and Answers for Monday, June 9
- Israeli forces seize Gaza aid boat carrying Greta Thunberg, ministry says
- Israel blocks Greta Thunberg’s ship from reaching Gaza, group says